Daejeon, South Korea

Kwang-Seok Oh


 

Average Co-Inventor Count = 7.5

ph-index = 1


Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kwang-Seok Oh: Innovator in PDE9A Inhibitory Compounds

Introduction

Kwang-Seok Oh is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds with PDE9A inhibitory activity. With a total of four patents to his name, his work has the potential to impact the treatment of various diseases.

Latest Patents

Kwang-Seok Oh's latest patents focus on compounds that exhibit PDE9A inhibitory activity. These inventions provide a specific chemical structure that can be utilized in pharmaceutical applications. The patents detail a composition containing these compounds or their pharmaceutically acceptable salts. Furthermore, they outline methods for treating or preventing PDE9A-related diseases by administering effective amounts of these compounds or compositions to patients in need.

Career Highlights

Throughout his career, Kwang-Seok Oh has worked with esteemed organizations such as the Korea Research Institute of Chemical Technology and Korea United Pharm, Inc. His experience in these institutions has allowed him to refine his expertise in chemical technology and pharmaceutical development.

Collaborations

Kwang-Seok Oh has collaborated with notable colleagues, including Kyu Yang Yi and Nack Jeong Kim. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Kwang-Seok Oh is a distinguished inventor whose work in PDE9A inhibitory compounds holds promise for future pharmaceutical applications. His contributions to the field are noteworthy and reflect his commitment to innovation in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…